Quivive's Executive Team
John Hsu, MD, CEO Founder
Peter Rix, DABT, Chief Scientific Officer
Peter Rix, DABT, Chief Scientific Officer
In addition to his 28 years as a practicing anesthesiologist and pain management specialist, Dr Hsu is a serial entrepreneur who has founded companies in the areas of medical devices and healthcare management software and consulting.
Peter Rix, DABT, Chief Scientific Officer
Peter Rix, DABT, Chief Scientific Officer
Peter Rix, DABT, Chief Scientific Officer
A drug development expert with 26 years of experience in pharmaceutical R&D, Peter has led or supported the development of six FDA-approved products and been involved in two major exits: Aragon to Janssen ($1B) and Saragon to Genetech-Roche ($1.75B)
Peter Weinstein, PhD, JD, General Counsel
Gary Seelhorst, MBA, Senior VP Business Development
Gary Seelhorst, MBA, Senior VP Business Development
A highly experienced patent litigator and former USPTO reviewer and attorney, Dr. Weinstein manages all aspects of intellectual property, transactions and corporate law. He also has significant pharma experience with support of two marketed products.
Gary Seelhorst, MBA, Senior VP Business Development
Gary Seelhorst, MBA, Senior VP Business Development
Gary Seelhorst, MBA, Senior VP Business Development
Gary has 23 years of clinical and corporate development experience with both large-cap and start-up pharmaceutical and medical device ventures, including marketing, in-licensing, strategic partnerships and M&A transactions.